Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:36:03 EDT Sun 11 May 2025
Enter Symbol
or Name
USA
CA



Q:CYTK - CYTOKINETICS INC - https://www.cytokinetics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CYTK - Q0.222.39·33.330.331.695-0.785-2.41,037.732,59812,14632.35  33.16  31.68564.61  31.6719:57:28May 0815 min RT 2¢

Recent Trades - Last 10 of 12146
Time ETExPriceChangeVolume
19:57:28Q31.72-0.7649
18:56:20Q32.2399-0.24011
16:57:55Q31.80-0.68300
16:40:04Q32.24-0.24625
16:33:28Q32.24-0.241
16:33:27Q32.229-0.2511
16:29:11Q32.24-0.24625
16:05:46Q31.55-0.931
16:05:08Q31.695-0.7851
16:05:06Q31.695-0.7851

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-05-08 16:00U:CYTKNews ReleaseCytokinetics Announces Four Upcoming Presentations at the European Society Of Cardiology Heart Failure 2025 Congress
2025-05-07 16:00U:CYTKNews ReleaseCytokinetics to Hold Annual Meeting of Stockholders
2025-05-06 16:00U:CYTKNews ReleaseCytokinetics Reports First Quarter 2025 Financial Results and Provides Business Update
2025-05-01 16:15U:CYTKNews ReleaseCytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy
2025-04-30 16:00U:CYTKNews ReleaseCytokinetics to Participate in May Investor Conferences
2025-04-22 16:00U:CYTKNews ReleaseCytokinetics to Announce First Quarter Results on May 6, 2025
2025-04-17 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-03-31 16:00U:CYTKNews ReleaseCytokinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference
2025-03-20 07:30U:CYTKNews ReleaseCytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community
2025-03-18 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-03-17 08:00U:CYTKNews ReleaseCytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo
2025-03-03 16:00U:CYTKNews ReleaseCytokinetics to Participate in March Investor Conferences
2025-02-27 16:00U:CYTKNews ReleaseCytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update
2025-02-19 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-02-13 16:00U:CYTKNews ReleaseCytokinetics to Announce Fourth Quarter Results on February 27, 2025
2025-02-11 07:30U:CYTKNews ReleaseCytokinetics Names Robert E. Landry to Board of Directors
2025-02-05 16:00U:CYTKNews ReleaseCytokinetics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
2025-02-04 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-01-30 07:30U:CYTKNews ReleaseCytokinetics Announces Recipients of Its Seventh Annual Communications Grant Program
2025-01-21 07:30U:CYTKNews ReleaseCytokinetics Announces Start of AMBER-HFpEF, a Phase 2 Clinical Trial of CK-586 in Patients With Symptomatic Heart Failure With Preserved Ejection Fraction